Steven Gillis

at Rapport Therapeutics Inc. (RAPP), 2024-06-10
at Boundless Bio Inc. (BOLD), 2024-04-04
Large Shareholder at Prime Medicine Inc. (PRME), 2024-02-20
Large Shareholder at Sana Biotechnology Inc. (SANA), 2024-02-12
Large Shareholder at Neumora Therapeutics Inc. (NMRA), 2023-12-13
Large Shareholder at Da32 Life Science Tech Acquisition Corp. (DALS), 2023-08-11
Director at Vbi Vaccines Inc (VBIV), 2023-07-28
at Homology Medicines Inc. (FIXX), 2023-06-15
Director at Codiak Biosciences Inc. (CDAK), 2023-02-21
Large Shareholder at Erasca Inc. (ERAS), 2021-07-21
Large Shareholder at Verve Therapeutics Inc. (VERV), 2021-06-23
Director at Pulmatrix Inc. (PULM), 2020-09-02
Director at Vbi Vaccines Inc. (VBIV), 2019-09-24
Large Shareholder at Sienna Biopharmaceuticals Inc. (SNNA), 2019-02-27
Large Shareholder, Director at Phaserx Inc. (PZRX), 2017-05-30
Director at Bluebird Bio Inc. (BLUE), 2015-07-30
Ex. Chair. & President at Trubion Pharmaceuticals Inc (TRBN), 2010-10-28

Insider Trading: Purchases See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Vbi Vaccines Inc	VBIV	$1.65	609,090	Director	1,043,292	2023-07-10	Filing
Codiak Biosciences Inc.	CDAK	$0.00	5,000,000	Director	7,503,903	2022-09-13	Filing
Codiak Biosciences Inc.	CDAK	$15.00	235,000	Director	2,503,903	2020-10-16	Filing
Vbi Vaccines Inc.	VBIV	$0.50	10,000,000	Director	13,026,057	2019-09-19	Filing
Pulmatrix Inc.	PULM	$0.00	1,150,000	Director	3,436,456	2018-04-03	Filing

Insider Trading: Sales See All

Company	Symbol	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Phaserx Inc.	PZRX	$0.01	195,156	Large Shareholder, Director	1,854,222	2016-05-23	Filing
Phaserx Inc.	PZRX	$0.01	484,903	Large Shareholder, Director	2,049,378	2016-05-23	Filing
Bluebird Bio Inc.	BLUE	$35.25	115,000	Director	1,041,111	2014-10-09	Filing
Bluebird Bio Inc.	BLUE	$35.15	6,700	Director	1,156,111	2014-10-07	Filing
Bluebird Bio Inc.	BLUE	$35.16	24,100	Director	1,162,811	2014-10-06	Filing